Physician, Professor
Neurology
Department: Neurology
I am a neurologist with a focus on the evaluation and management of patients with dizziness, vertigo, and balance problems – specifically neurologic and vestibular disorders. I also perform research that aims to define current practice and discover, develop, validate, and implement processes that optimize meaningful outcomes and contribute to a sustainable healthcare system.
Please note: Not all physicians schedule patients at each listed location.
I am trained in neurology at the University of Michigan and neurotology at the University of California, Los Angeles. I completed a master’s degree in Health and Healthcare Research at UM. I was on the faculty of UM before joining Ohio State to co-found the HSR Neurology. My grant funding, from the National Institutes of Health and Agency for Healthcare Research and Quality, has included projects about the clinical epidemiology of dizziness, clinical decision rule development to identify stroke in acute dizziness presentations, health services randomized clinical trials to implement evidence-based care practices in routine care emergency departments, and the development and evaluation of patient-oriented behavioral interventions. I am particularly interested in the development and management of patient-focused resources.
I am currently collaborating with Kaiser Permanente Southern California on an NIH-funded clinical trial of a provider- and patient-based implementation strategy to optimize management and outcomes for ED dizziness presentations. I have also evaluated payment policies and collaborated with other investigators across a variety of topics including stroke epidemiology, geographic variation in neurologists and neurologic care, and the value of neurologic care. I serve as a Vice-Chair of Clinical Operations and the Director of the Neuro-otology program.
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 11/3/2025, Kevin Kerber has reported no relationships with companies or entities.